Looks like a little more healthy activity today. I couldn't resist a small purchase of 1500 shares at £1.26 and was pleased to see a purchase of 15000 at the same price shortly after mine. As I said yesterday feels like we could have bottomed out at this level again. Good luck everyone, we are getting ever closer to news I feel.
Chrisatrdg..Thank you for that..not a huge story but something to learn about one of our larger shareholders. The 1share trade today, is it a signal that an RNS is coming in the morning, will be tested. I personally do not believe it but you never know. Got back to the recent low once again..wont be long till se get some uplift I feel. Getting closer and closer to news from across the water on C Difficile. I reminded my self today that in this form the price got to £4 last year..so many good RNS's since just does not make sense. But it does tell me that any good news from C Diff and we will absolutely fly. GL
Richard Griffiths contd
Daily Mail extract 'Entrepreneur and major 17 per cent shareholder Richard Griffiths pulled off a coup when he installed Chris Richards as non-executive chairman of Plant Health Care in August 2012. He’d already enjoyed a distinguished career in the global agrochemical industry and was instrumental in transforming Arysta LifeScience into a global agrochemical company with one of the fastest growth rates in the industry with sales above £1billion. His appointment escaped the market’s notice, that is until yesterday. Dealers heard that Arysta LifeScience had succumbed to an agreed £2.24billion offer from Platform Specialty Products backed by London-based private equity firm, Permira. The news prompted hopes that Richards will now weave his magic at Plant Health Care and transform it into an attractive takeover target. Buyers piled in and the close was 6.6p or 9 per cent higher at a year’s peak of 81.5p. Richards put his money where his mouth is in April when he bought another 5,000 shares at 59p which increased his shareholding to 61,500. His buying will probably not stop there as he builds the company up into an attractive takeover target.'
Article in the Daily Mail market report section about entrepreneur Richard Griffiths dealings with another pharmaceutical company. Looks like a pretty shrewd cookie to me.Not able to copy over to this board unfortunately. RG had 5.15% of Summit at the last count I believe. GL
Hi All - The next phase for DMD post phase 1b is due to start by December so not yet overdue. With regards what are they doing and the time taken I expect that they need to ensure that all is correct by dotting the i's and crossing the t's as they cannot afford for the pre phase 2 trial not to work this time. As someone said earlier 'keep the faith' and remember that c-diff is at stage 2 which if the trials work will have a significant effect on the SP. GLA
Yes targets slipping seems to be the norm, I haven't double checked but sure we were expecting some news by now on the DMD Phase 1B trial. I don't have a medical background so it's very difficult to understand why it takes so long to address a dietary issue, there would appear to be no shortage of patients willing to take part in the trials (understandably). Hopefully news soon.
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.